Literature DB >> 19064594

Comparison of pulmonary CT findings and serum KL-6 levels in patients with cryptogenic organizing pneumonia.

F Okada1, Y Ando, K Honda, S Tanoue, S Matsumoto, H Mori.   

Abstract

The aim of this study was to retrospectively compare high-resolution CT findings among cryptogenic organizing pneumonia (COP) patients with normal and elevated serum KL-6 levels. Chest CT scans performed between April 1999 and April 2007 in 20 COP patients with a normal KL-6 level and 17 COP patients with an elevated KL-6 level were evaluated retrospectively by two chest radiologists. The CT findings in the COP patients with either a normal or an elevated KL-6 level mainly consisted of consolidation (n = 17 and n = 13, respectively) followed by ground-glass opacity (n = 11 and n = 13, respectively). Traction bronchiectasis and architectural distortion were significantly more frequent in patients with an elevated KL-6 level than in those with normal levels (n = 7 and n = 1, and n = 13 and n = 3, respectively) (p = 0.0077 and p = 0.00017, respectively). In follow-up CT scans, a relapse within 1 year after initial treatment with steroids, performed in 16 patients with a normal KL-6 level and 16 with an elevated KL-6 level, occurred in 2 (12.5%) patients with a normal KL-6 level and in 6 (37.5%) with an elevated KL-6 level. The frequency of relapse in patients with an elevated KL-6 level was higher than in those with a normal KL-6 level; however, no significant difference between the two groups was observed (p = 0.103). In conclusion, CT findings of traction bronchiectasis and architectural distortion in COP patients are associated with increased serum KL-6 levels, which might be related to a relapse after treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19064594     DOI: 10.1259/bjr/72775434

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  10 in total

1.  Comparison of pulmonary thin section CT findings and serum KL-6 levels in patients with sarcoidosis.

Authors:  K Honda; F Okada; Y Ando; H Mori; K Umeki; H Ishii; J Kadota; M Ando; E Miyazaki; T Kumamoto
Journal:  Br J Radiol       Date:  2010-11-02       Impact factor: 3.039

2.  Serum KL-6 and surfactant protein-D as monitoring and predictive markers of interstitial lung disease in patients with systemic sclerosis and mixed connective tissue disease.

Authors:  Hideaki Yamakawa; Eri Hagiwara; Hideya Kitamura; Yumie Yamanaka; Satoshi Ikeda; Akimasa Sekine; Tomohisa Baba; Koji Okudela; Tae Iwasawa; Tamiko Takemura; Kazuyoshi Kuwano; Takashi Ogura
Journal:  J Thorac Dis       Date:  2017-02       Impact factor: 2.895

3.  Clinico-pathological analysis referring hemeoxygenase-1 in acute fibrinous and organizing pneumonia patients.

Authors:  Yu Hara; Masaharu Shinkai; Soichiro Kanoh; Akihiko Kawana; Bruce K Rubin; Osamu Matsubara; Takeshi Kaneko
Journal:  Respir Med Case Rep       Date:  2015-01-30

4.  CT patterns of organizing pneumonia in patients treated with VEGF/mTOR inhibitors for metastatic renal cell cancer: an observational study.

Authors:  Sabine Dettmer; Viktor Grünwald; Thomas Fuehner; Arnold Ganser; Frank Wacker; Philipp Ivanyi; Thomas Rodt
Journal:  Acta Radiol Open       Date:  2017-02-01

5.  Rapidly progressive organizing pneumonia associated with COVID-19.

Authors:  Hiroshi Horii; Keisuke Kamada; Sho Nakakubo; Yu Yamashita; Junichi Nakamura; Yasuyuki Nasuhara; Satoshi Konno
Journal:  Respir Med Case Rep       Date:  2020-11-18

6.  Seroradiologic prognostic evaluation of acute exacerbation in patients with idiopathic interstitial pneumonia: a retrospective observational study.

Authors:  Toru Arai; Masanori Akira; Chikatoshi Sugimoto; Kazunobu Tachibana; Yasushi Inoue; Sayoko Shintani; Tomohisa Okuma; Takahiko Kasai; Seiji Hayashi; Yoshikazu Inoue
Journal:  J Thorac Dis       Date:  2020-08       Impact factor: 2.895

7.  Comparison of Clinical Features between the High and Low Serum KL-6 Patients with Acute Exacerbation of Interstitial Lung Diseases.

Authors:  Yoichi Tagami; Yu Hara; Kota Murohashi; Ryo Nagasawa; Yurika Nishikawa; Meiro Tanaka; Ayako Aoki; Katsushi Tanaka; Kentaro Nakashima; Keisuke Watanabe; Nobuyuki Horita; Nobuaki Kobayashi; Masaki Yamamoto; Makoto Kudo; Koji Okudela; Takeshi Kaneko
Journal:  Can Respir J       Date:  2021-11-30       Impact factor: 2.409

8.  Changes in serum transforming growth factor-beta concentration as a predictive factor for radiation-induced lung injury onset in radiotherapy-treated patients with locally advanced lung cancer.

Authors:  Yurie Seto; Yoshiko Kaneko; Takako Mouri; Daisuke Shimizu; Yoshie Morimoto; Shinsaku Tokuda; Masahiro Iwasaku; Tadaaki Yamada; Koichi Takayama
Journal:  Transl Lung Cancer Res       Date:  2022-09

9.  Serum KL-6 can distinguish between different phenotypes of severe COVID-19.

Authors:  Hideta Nakamura; Kazuya Miyagi; Mariko Otsuki; Yuri Higure; Naoya Nishiyama; Takeshi Kinjo; Masashi Nakamatsu; Shusaku Haranaga; Masao Tateyama; Jiro Fujita
Journal:  J Med Virol       Date:  2020-07-19       Impact factor: 20.693

10.  Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Complicated with Organizing Pneumonia.

Authors:  Chiaki Hosoda; Takashi Ishiguro; Yasuhiro Morimoto; Atsuki Furube; Taisuke Isono; Yoshihiko Shimizu; Noboru Takayanagi
Journal:  Intern Med       Date:  2020-01-17       Impact factor: 1.271

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.